MSD, Daiichi Sankyo’s ifinatamab deruxtecan receives FDA priority

The BLA submission for ifinatamab deruxtecan draws on data from the IDeate-Lung01 Phase II trial. Credit: 89stocker / ...
Yahoo Finance

MSD pays up to nearly $600m for Evaxion’s mystery vaccine candidate

Stakeholders are reluctant to publicly speculate on how much thresholds should be increased. Credit: Iryna Imago via Shutterstock. · Pharmaceutical Technology · Iryna Imago via Shutterstock. Merck & ...

MSD secures EC clearance for Keytruda combination therapy for ovarian cancer

The approval also covers Keytruda SC, known in the US as Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph).
CNBCTV18

Aurobindo Pharma arm expands MSD pact, to set up $150-175 million facility

Under the agreement, TheraNym will establish a large-scale mammalian cell culture-based facility with a total bioreactor ...
pharmaphorum

MSD said to have pulled back from Revolution Meds deal

Negotiations between MSD and Revolution Medicines over a possible takeover – estimated to have been potentially worth up to $30 billion – have reportedly ended without agreement. That is according to ...
Mountain Xpress

MSD upgrades its infrastructure with capital improvement projects

WASTE WATCHERS: Largely unheralded, the Buncombe County Metropolitan Sewerage District ensures that the waste generated by its approximately 130,000 customers is properly treated and disposed of ...